Bryan Kestenbaum spends much of his time researching Internal medicine, Kidney disease, Surgery, Endocrinology and Renal function. His study in Internal medicine focuses on End stage renal disease, Cohort study, Nephrology, Vitamin D and neurology and Prospective cohort study. His Kidney disease research is multidisciplinary, incorporating perspectives in Relative risk, Intensive care medicine, Dialysis, National Health and Nutrition Examination Survey and Risk factor.
His work in Surgery addresses issues such as Hip fracture, which are connected to fields such as Retrospective cohort study. His Endocrinology research incorporates elements of Gastroenterology, Parathyroid hormone, Fibroblast growth factor 23 and Heart failure. His Renal function research includes elements of Creatinine, Gait, Ambulatory and Cardiology.
His primary areas of study are Internal medicine, Endocrinology, Kidney disease, Renal function and Cardiology. His Internal medicine study frequently draws connections between related disciplines such as Diabetes mellitus. Bryan Kestenbaum has researched Endocrinology in several fields, including Gastroenterology and Parathyroid hormone, Fibroblast growth factor 23.
His Kidney disease research is multidisciplinary, incorporating elements of End stage renal disease, Hemodialysis, Dialysis, Cohort and Risk factor. His Renal function research is multidisciplinary, relying on both Kidney, Confidence interval and Urology. Bryan Kestenbaum combines subjects such as Incidence and Left ventricular hypertrophy, Blood pressure with his study of Cardiology.
His main research concerns Internal medicine, Renal function, Kidney disease, Endocrinology and Cardiology. As part of his studies on Internal medicine, he frequently links adjacent subjects like Diabetes mellitus. Bryan Kestenbaum has included themes like Urine, Kidney, Confidence interval and Urology in his Renal function study.
His studies deal with areas such as Gastroenterology, Biomarker and Cohort study as well as Kidney disease. His study in Endocrinology is interdisciplinary in nature, drawing from both Parathyroid hormone and Clinical significance. His studies in Cardiology integrate themes in fields like Mineral metabolism, Left ventricular hypertrophy, Blood pressure, Lower risk and Subclinical infection.
Bryan Kestenbaum mostly deals with Internal medicine, Kidney disease, Renal function, Endocrinology and Cardiology. His Internal medicine study frequently intersects with other fields, such as Diabetes mellitus. The concepts of his Kidney disease study are interwoven with issues in Biomarker, Metabolome, Endothelium and Creatinine.
Bryan Kestenbaum interconnects Gastroenterology, Inflammation, Hazard ratio, Prospective cohort study and Kidney in the investigation of issues within Renal function. His Endocrinology study incorporates themes from Nephrology, ABO blood group system and Locus. His Cardiology research integrates issues from Mineral metabolism, Incidence, Pathogenesis and Confounding.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Kidney Disease and Increased Mortality Risk in Type 2 Diabetes
Maryam Afkarian;Michael C. Sachs;Bryan Kestenbaum;Irl B. Hirsch.
Journal of The American Society of Nephrology (2013)
Effects of Phosphate Binders in Moderate CKD
Geoffrey A. Block;David C. Wheeler;Martha S. Persky;Bryan Kestenbaum.
Journal of The American Society of Nephrology (2012)
Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative.
Ian H. de Boer;Lesley F. Tinker;Stephanie Connelly;J. David Curb.
Diabetes Care (2008)
Elevated risk of stroke among patients with end-stage renal disease
Stephen L. Seliger;Daniel L. Gillen;W.T. Longstreth;Bryan Kestenbaum.
Kidney International (2003)
Vitamin D and the risk of dementia and Alzheimer disease
Thomas J. Littlejohns;William E. Henley;Iain A. Lang;Cedric Annweiler.
Risk of hip fracture among dialysis and renal transplant recipients.
Adrianne M. Ball;Daniel L. Gillen;Donald Sherrard;Noel S. Weiss.
Association of Serum Phosphate with Vascular and Valvular Calcification in Moderate CKD
Kathryn L. Adeney;David S. Siscovick;Joachim H. Ix;Stephen L. Seliger.
Journal of The American Society of Nephrology (2009)
HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients.
Stephen L. Seliger;Noel S. Weiss;Noel S. Weiss;Noel S. Weiss;Daniel L. Gillen;Daniel L. Gillen;Daniel L. Gillen;Bryan Kestenbaum;Bryan Kestenbaum;Bryan Kestenbaum.
Kidney International (2002)
25-Hydroxyvitamin D Levels and Albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III)
Ian H. de Boer;George N. Ioannou;Bryan Kestenbaum;John D. Brunzell.
American Journal of Kidney Diseases (2007)
Association of Oral Calcitriol with Improved Survival in Nondialyzed CKD
Abigail B. Shoben;Kyle D. Rudser;Ian H. de Boer;Bessie Young.
Journal of The American Society of Nephrology (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: